<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15540">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00137280</url>
  </required_header>
  <id_info>
    <org_study_id>MNT 03-213</org_study_id>
    <secondary_id>P30MH082760</secondary_id>
    <nct_id>NCT00137280</nct_id>
  </id_info>
  <brief_title>Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)</brief_title>
  <acronym>EQUIP-2</acronym>
  <official_title>Implementing Effective, Collaborative Care for Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project evaluates the implementation and effectiveness of a care model to improve
      treatment for schizophrenia within the context of diverse VA practices and priorities. The
      project provides information to VA clinicians and managers about Veterans with schizophrenia
      or schizoaffective disorder who are overweight and/or who would like to return to
      competitive work. The project facilitates reorganization of care practices in order to get
      veterans needed and desired services around wellness and work. The project creates a
      platform that other clinical and research interventions can build upon to improve care, and
      is designed to inform a national strategy for implementing evidence-based care in
      schizophrenia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      EQUIP-2 is a clinic-level controlled trial. From the four participating Veterans Integrated
      Services Networks (VISNs), eight specialty mental health programs were enrolled and assigned
      to care as usual or to receive an intervention supporting evidence-based quality improvement
      and use of a chronic illness care model. Participants are VISN 3 (James J. Peters VA;
      Northport VA); VISN 16 (Houston VA; Shreveport VA); VISN 17 (Waco VA; Temple VA); and VISN
      22 (Long Beach VA; Greater Los Angeles VA). The objectives of this VA Quality Enhancement
      Research Initiative (QUERI) Service Directed Project are 1) assist in identifying and making
      available recovery-oriented services to veterans with schizophrenia; 2) implement
      information systems that efficiently and accurately identify patient status and who would be
      appropriate for these services; 3) implement a care model to support recovery-oriented care
      delivery; 4) evaluate, in a controlled trial, the effect of implementation on treatment
      delivery and patient outcomes; and 5) identify facilitators and barriers to wellness program
      participation in an effort to strengthen the weight management services available to
      patients with schizophrenia. The project studies intervention feasibility, acceptability,
      and impact on outcomes; performs qualitative analyses examining processes and variation in
      care model implementation and impact. Research includes a controlled trial of the impact of
      implementation, relative to usual care, on treatment quality. Participants include clinic
      staff and patients with schizophrenia. Data sources include interviews with participants,
      focus groups with a sub-set of patients, implementation documentation, the project
      informatics system, and VistA.

      Methods:

      The care model targets two clinical domains selected by the VISNs from the following:
      Supported Employment (SE), caregiver support, wellness programs, or clozapine. All 4 VISNs
      chose the same two targets: SE and wellness. The care model includes: 1) at each visit,
      routine collection of patient outcomes data and provision of decision support using a
      self-assessment kiosk; 2) provision of &quot;psychiatric vital signs&quot; to patients and clinicians
      at the time of the clinical encounter via report that prints from the kiosk; 3) education
      and activation of both clinicians and patients around the clinical targets; 4) regular
      reports identifying patients appropriate for services associated with these targets; and 5)
      facilitation of problem-solving and evidence-based quality improvement addressing any
      barriers to utilization of these services.

      To inform future wellness implementation, in-depth, semi-structured interviews are conducted
      with patients who participated in wellness groups (&quot;participants&quot;), and with patients who
      were referred (because they were overweight or obese) but did not participate
      (&quot;non-participants&quot;). Participants consist of all enrolled patients who attended the
      wellness program with special attention to those patients who completed at least half of the
      wellness program. Non-participants consist of patients who were referred to the wellness
      program but did not attend. Clinicians were interviewed specifically regarding wellness
      implementation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>The Effect of Care Model Implementation on Treatment Appropriateness: Weight Service Utilization</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of participants with one or more weight service appointments in the one year during implementation (implementation sites versus control sites) for those participants who were overweight at the baseline interview (e.g., eligible for weight services). This only includes participants who were overweight at the baseline interview (e.g., eligible for weight services).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Weight Outcomes</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Analysis of Covariance (ANCOVA) was used to examine weight gained during treatment in implementation versus control groups. The dependent variable was final weight. Baseline weight, weight 6 months prior to baseline, and baseline psychotic and negative symptom subscales were included as covariates. The inclusion of weight 6 months prior to baseline served to control for subjects' weight gain/loss trajectories prior to entering the study. The two-way interactions of group by covariates were also included in the model.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Effect of Care Model Implementation on Treatment Appropriateness: Supported Employment Utilization</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The number of participants with one or more Supported Employment appointments in the one year during implementation (implementation sites versus control sites) for those participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services). This only includes participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Employment Outcomes</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Chi-square analysis was used to examine competitive employment gained during treatment in implementation versus control groups. The dependent variable was competitive employment. Individuals included were only those who expressed interest in returning to work at both the baseline and follow-up interview time-points.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1067</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Chronic Illness</condition>
  <condition>Weight Gain</condition>
  <condition>Psychotic Disorder</condition>
  <arm_group>
    <arm_group_label>Collaborative Chronic Illness Care Model</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collaborative Chronic Illness Care Model: A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Collaborative Chronic Illness Care Model</intervention_name>
    <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
    <arm_group_label>Collaborative Chronic Illness Care Model</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinicians and Managers:

          -  Psychiatrists, Case Managers, Nurses, Supported Employment workers Nutritionists,
             Local Recovery Coordinators, and Quality Improvement experts working at one of the
             participating VA Medical Centers

        Patients:

          -  At least 18 years old

          -  Diagnosis of Schizophrenia, Schizoaffective, or schizophreniform disorder

          -  At least 1 treatment visit with a clinician at the clinic during the 6 months prior
             to enrollment and then at least 1 treatment visit with a clinician at the clinic
             during the 5 months of enrollment.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Stehle Young, MD MSHS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Long Beach Healthcare System, Long Beach, CA</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Greater Los Angeles Healthcare System, West Los Angeles, CA</name>
      <address>
        <city>West Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overton Brooks VA Medical Center, Shreveport, LA</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Southern Nevada Healthcare System, North Las Vegas, NV</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James J. Peters VA Medical Center, Bronx, NY</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northport VA Medical Center, Northport, NY</name>
      <address>
        <city>Northport</city>
        <state>New York</state>
        <zip>11768</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michael E. DeBakey VA Medical Center, Houston, TX</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Texas Veterans Health Care System, Temple, TX</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Young AS, Niv N, Cohen AN, Kessler C, McNagny K. The appropriateness of routine medication treatment for schizophrenia. Schizophr Bull. 2010 Jul;36(4):732-9. doi: 10.1093/schbul/sbn138. Epub 2008 Nov 7.</citation>
    <PMID>18997159</PMID>
  </reference>
  <reference>
    <citation>Niv N, Shatkin JP, Hamilton AB, Unützer J, Klap R, Young AS. The use of herbal medications and dietary supplements by people with mental illness. Community Ment Health J. 2010 Dec;46(6):563-9. doi: 10.1007/s10597-009-9235-2. Epub 2009 Aug 18.</citation>
    <PMID>19688594</PMID>
  </reference>
  <reference>
    <citation>Young AS, Klap R, Shoai R, Wells KB. Persistent depression and anxiety in the United States: prevalence and quality of care. Psychiatr Serv. 2008 Dec;59(12):1391-8. doi: 10.1176/appi.ps.59.12.1391.</citation>
    <PMID>19033165</PMID>
  </reference>
  <reference>
    <citation>Cohen AN, Glynn SM, Murray-Swank AB, Barrio C, Fischer EP, McCutcheon SJ, Perlick DA, Rotondi AJ, Sayers SL, Sherman MD, Dixon LB. The family forum: directions for the implementation of family psychoeducation for severe mental illness. Psychiatr Serv. 2008 Jan;59(1):40-8. doi: 10.1176/appi.ps.59.1.40.</citation>
    <PMID>18182538</PMID>
  </reference>
  <results_reference>
    <citation>Young AS, Niv N, Chinman M, Dixon L, Eisen SV, Fischer EP, Smith J, Valenstein M, Marder SR, Owen RR. Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI. Community Ment Health J. 2011 Apr;47(2):123-35. doi: 10.1007/s10597-010-9328-y. Epub 2010 Jul 25.</citation>
    <PMID>20658320</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen AN, Glynn SM, Hamilton AB, Young AS. Implementation of a family intervention for individuals with schizophrenia. J Gen Intern Med. 2010 Jan;25 Suppl 1:32-7. doi: 10.1007/s11606-009-1136-0.</citation>
    <PMID>20077149</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamilton AB, Cohen AN, Young AS. Organizational readiness in specialty mental health care. J Gen Intern Med. 2010 Jan;25 Suppl 1:27-31. doi: 10.1007/s11606-009-1133-3.</citation>
    <PMID>20077148</PMID>
  </results_reference>
  <results_reference>
    <citation>Brown AH, Cohen AN, Chinman MJ, Kessler C, Young AS. EQUIP: implementing chronic care principles and applying formative evaluation methods to improve care for schizophrenia: QUERI Series. Implement Sci. 2008 Feb 15;3:9. doi: 10.1186/1748-5908-3-9.</citation>
    <PMID>18279505</PMID>
  </results_reference>
  <results_reference>
    <citation>Niv N, Cohen AN, Hamilton A, Reist C, Young AS. Effectiveness of a psychosocial weight management program for individuals with schizophrenia. J Behav Health Serv Res. 2014 Jul;41(3):370-80. doi: 10.1007/s11414-012-9273-3.</citation>
    <PMID>22430566</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen AN, Chinman MJ, Hamilton AB, Whelan F, Young AS. Using patient-facing kiosks to support quality improvement at mental health clinics. Med Care. 2013 Mar;51(3 Suppl 1):S13-20. doi: 10.1097/MLR.0b013e31827da859.</citation>
    <PMID>23407006</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamilton AB, Cohen AN, Glover DL, Whelan F, Chemerinski E, McNagny KP, Mullins D, Reist C, Schubert M, Young AS. Implementation of evidence-based employment services in specialty mental health. Health Serv Res. 2013 Dec;48(6 Pt 2):2224-44. doi: 10.1111/1475-6773.12115. Epub 2013 Oct 21.</citation>
    <PMID>24138608</PMID>
  </results_reference>
  <results_reference>
    <citation>Armstrong NP, Cohen AN, Hellemann G, Reist C, Young AS. Validating a brief version of the Mental Health Recovery Measure for individuals with schizophrenia. Psychiatr Serv. 2014 Sep 1;65(9):1154-9. doi: 10.1176/appi.ps.201300215.</citation>
    <PMID>24828568</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <lastchanged_date>April 6, 2015</lastchanged_date>
  <firstreceived_date>August 25, 2005</firstreceived_date>
  <firstreceived_results_date>October 3, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Quality of Health Care</keyword>
  <keyword>Health Services Research</keyword>
  <keyword>Guidelines</keyword>
  <keyword>Medical Informatics Computing</keyword>
  <keyword>Services, Mental Health</keyword>
  <keyword>Medicine, Evidenced-Based</keyword>
  <keyword>Quality Assurance, Healthcare</keyword>
  <keyword>Quality Indicators, Health Care</keyword>
  <keyword>Veterans</keyword>
  <keyword>Unemployment</keyword>
  <keyword>Obesity</keyword>
  <keyword>Quality Improvement</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Disease</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Weight Gain</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were selected randomly from the population of individuals with schizophrenia receiving care at VA mental health clinics. All clinicians and managers at mental health clinics were selected.</recruitment_details>
      <pre_assignment_details>Patients were excluded if they did not meet inclusion criteria, refused to participate, or were not approached about participation. Staff were excluded if they refused to participate.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Collaborative Chronic Illness Care Model</title>
          <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>Continue with usual care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="389"/>
                <participants group_id="P2" count="412"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="305"/>
                <participants group_id="P2" count="357"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>People with schizophrenia</population>
      <group_list>
        <group group_id="B1">
          <title>Collaborative Chronic Illness Care Model</title>
          <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>Continue with usual care</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="389"/>
                <measurement group_id="B2" value="412"/>
                <measurement group_id="B3" value="801"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="54.0" spread="9.3"/>
                <measurement group_id="B2" value="54.5" spread="9.5"/>
                <measurement group_id="B3" value="54.3" spread="9.4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
                <measurement group_id="B2" value="39"/>
                <measurement group_id="B3" value="69"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="359"/>
                <measurement group_id="B2" value="373"/>
                <measurement group_id="B3" value="732"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="13"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="6"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="5"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="160"/>
                <measurement group_id="B2" value="195"/>
                <measurement group_id="B3" value="355"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="175"/>
                <measurement group_id="B2" value="180"/>
                <measurement group_id="B3" value="355"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11"/>
                <measurement group_id="B2" value="4"/>
                <measurement group_id="B3" value="15"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="33"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="52"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="72"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="100"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Not Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="312"/>
                <measurement group_id="B2" value="380"/>
                <measurement group_id="B3" value="692"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
                <measurement group_id="B2" value="4"/>
                <measurement group_id="B3" value="9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="389"/>
                <measurement group_id="B2" value="412"/>
                <measurement group_id="B3" value="801"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Duration with Schizophrenia, years</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="26.2" spread="11.7"/>
                <measurement group_id="B2" value="25.8" spread="12.7"/>
                <measurement group_id="B3" value="26.0" spread="12.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Psychotropic medications by weight gain potential</title>
          <description>Participants are only counted in one category; Participants are counted in the highest weight gain potential category.</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>High Weight Gain Potential</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="70"/>
                <measurement group_id="B2" value="65"/>
                <measurement group_id="B3" value="135"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Moderate Weight Gain Potential</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="149"/>
                <measurement group_id="B2" value="158"/>
                <measurement group_id="B3" value="307"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Low Weight Gain Potential</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="96"/>
                <measurement group_id="B2" value="92"/>
                <measurement group_id="B3" value="188"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown/Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="74"/>
                <measurement group_id="B2" value="97"/>
                <measurement group_id="B3" value="171"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Weight, kilograms</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="94.6" spread="20.4"/>
                <measurement group_id="B2" value="93.0" spread="20.1"/>
                <measurement group_id="B3" value="93.8" spread="20.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="30.2" spread="6.1"/>
                <measurement group_id="B2" value="29.9" spread="6.5"/>
                <measurement group_id="B3" value="30.1" spread="6.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Diagnosis of Diabetes</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Yes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="120"/>
                <measurement group_id="B2" value="118"/>
                <measurement group_id="B3" value="238"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="269"/>
                <measurement group_id="B2" value="294"/>
                <measurement group_id="B3" value="563"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Waist Circumference, centimeters</title>
          <units>centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="104.9" spread="16.3"/>
                <measurement group_id="B2" value="104.3" spread="15.7"/>
                <measurement group_id="B3" value="104.6" spread="16.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Psychotic Symptoms, Brief Psychiatric Rating Scale</title>
          <description>The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The psychotic symptoms scale measures severity of psychosis.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="2.3" spread="1.3"/>
                <measurement group_id="B2" value="2.5" spread="1.3"/>
                <measurement group_id="B3" value="2.4" spread="1.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Negative Symptoms, Brief Psychiatric Rating Scale</title>
          <description>The Brief Psychiatric Rating Scale includes a number of scales that measure domains of psychopathology. Item scores and scale scores range from 1 (none) to 7 (extremely severe). The negative symptoms scale measures severity of negative symptoms.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="1.5" spread="0.8"/>
                <measurement group_id="B2" value="2.0" spread="1.3"/>
                <measurement group_id="B3" value="1.8" spread="0.8"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Functioning, Global Assessment of Functioning Scale</title>
          <description>The Global Assessment of Functioning Scale consists of three scales: occupational functioning, social functioning, and symptomatic functioning. Each scale ranges from 1 (worst possible functioning) to 100 (superior functioning).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <sub_title>Occupational Functioning</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="39.5" spread="20.6"/>
                <measurement group_id="B2" value="38.2" spread="16.8"/>
                <measurement group_id="B3" value="38.8" spread="18.8"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Social Functioning</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="53.4" spread="14.1"/>
                <measurement group_id="B2" value="54.4" spread="12.9"/>
                <measurement group_id="B3" value="53.9" spread="13.5"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Symptomatic Functioning</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="53.4" spread="15.1"/>
                <measurement group_id="B2" value="50.2" spread="13.8"/>
                <measurement group_id="B3" value="51.7" spread="14.5"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Effect of Care Model Implementation on Treatment Appropriateness: Weight Service Utilization</title>
        <description>The number of participants with one or more weight service appointments in the one year during implementation (implementation sites versus control sites) for those participants who were overweight at the baseline interview (e.g., eligible for weight services). This only includes participants who were overweight at the baseline interview (e.g., eligible for weight services).</description>
        <time_frame>1 year</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Chronic Illness Care Model</title>
            <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Continue with usual care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="308"/>
                  <measurement group_id="O2" value="315"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Effect of Care Model Implementation on Treatment Appropriateness: Weight Service Utilization</title>
            <description>The number of participants with one or more weight service appointments in the one year during implementation (implementation sites versus control sites) for those participants who were overweight at the baseline interview (e.g., eligible for weight services). This only includes participants who were overweight at the baseline interview (e.g., eligible for weight services).</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="73"/>
                  <measurement group_id="O2" value="38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.01</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.47</ci_lower_limit>
            <ci_upper_limit>3.58</ci_upper_limit>
            <estimate_desc>Comparison group is the control (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Weight Outcomes</title>
        <description>Analysis of Covariance (ANCOVA) was used to examine weight gained during treatment in implementation versus control groups. The dependent variable was final weight. Baseline weight, weight 6 months prior to baseline, and baseline psychotic and negative symptom subscales were included as covariates. The inclusion of weight 6 months prior to baseline served to control for subjects’ weight gain/loss trajectories prior to entering the study. The two-way interactions of group by covariates were also included in the model.</description>
        <time_frame>1 year</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Chronic Illness Care Model</title>
            <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Continue with usual care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="273"/>
                  <measurement group_id="O2" value="332"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Weight Outcomes</title>
            <description>Analysis of Covariance (ANCOVA) was used to examine weight gained during treatment in implementation versus control groups. The dependent variable was final weight. Baseline weight, weight 6 months prior to baseline, and baseline psychotic and negative symptom subscales were included as covariates. The inclusion of weight 6 months prior to baseline served to control for subjects’ weight gain/loss trajectories prior to entering the study. The two-way interactions of group by covariates were also included in the model.</description>
            <units>pounds</units>
            <param>Least Squares Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="208.1" spread=".92"/>
                  <measurement group_id="O2" value="207.2" spread=".83"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>.03</p_value>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>13.02</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>5.93</dispersion_value>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Effect of Care Model Implementation on Treatment Appropriateness: Supported Employment Utilization</title>
        <description>The number of participants with one or more Supported Employment appointments in the one year during implementation (implementation sites versus control sites) for those participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services). This only includes participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services).</description>
        <time_frame>1 year</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Chronic Illness Care Model</title>
            <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Continue with usual care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="194"/>
                  <measurement group_id="O2" value="212"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Effect of Care Model Implementation on Treatment Appropriateness: Supported Employment Utilization</title>
            <description>The number of participants with one or more Supported Employment appointments in the one year during implementation (implementation sites versus control sites) for those participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services). This only includes participants who endorsed a desire to return to work at the baseline interview (e.g., eligible for Supported Employment services).</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="32"/>
                  <measurement group_id="O2" value="17"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.01</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.22</ci_lower_limit>
            <ci_upper_limit>4.34</ci_upper_limit>
            <estimate_desc>Comparison group is the control (denominator)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Employment Outcomes</title>
        <description>Chi-square analysis was used to examine competitive employment gained during treatment in implementation versus control groups. The dependent variable was competitive employment. Individuals included were only those who expressed interest in returning to work at both the baseline and follow-up interview time-points.</description>
        <time_frame>1 year</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Chronic Illness Care Model</title>
            <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>Continue with usual care</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="96"/>
                  <measurement group_id="O2" value="148"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>The Effect of Care Model Implementation on Treatment Appropriateness: Patient Employment Outcomes</title>
            <description>Chi-square analysis was used to examine competitive employment gained during treatment in implementation versus control groups. The dependent variable was competitive employment. Individuals included were only those who expressed interest in returning to work at both the baseline and follow-up interview time-points.</description>
            <units>competitive employment</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="14"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>.11</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Collaborative Chronic Illness Care Model</title>
          <description>A care model that integrates greater availability of clinical information, reorganizes the practice system and provider roles, fosters care coordination, and focuses on evidence-based protocols--specifically supported employment and wellness services for individuals with schizophrenia.</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>Continue with usual care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="389"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="412"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="389"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="412"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alexander S. Young</name_or_title>
      <organization>Greater Los Angeles Veterans Healthcare Center</organization>
      <phone>310-268-3416</phone>
      <email>alexander.young@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
